TrialAntiviral research2019

Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection.

Sunwen Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.